SCHEMBL5340574

SCHEMBL5340574

CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(C(=O)CBr)cn2)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
L3MBTL1 Q9Y468 1/20 0.55
HDAC3 O15379 5/20 0.55
HDAC4 P56524 5/20 0.55
HDAC1 Q13547 5/20 0.55
HDAC7 Q8WUI4 5/20 0.55
HDAC2 Q92769 5/20 0.55
HDAC10 Q969S8 5/20 0.55
HDAC11 Q96DB2 5/20 0.55
HDAC8 Q9BY41 5/20 0.55
HDAC6 Q9UBN7 5/20 0.55
HDAC9 Q9UKV0 5/20 0.55
HDAC5 Q9UQL6 5/20 0.55
ATIC P31939 1/20 0.54
ALDH1A1 P00352 3/20 0.53
BDKRB1 P46663 1/20 0.49
AKT1 P31749 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5315898 0.87 KDM4E (0.64) KDM4EL3MBTL1ATICALDH1A1BDKRB1
SCHEMBL5318602 0.85 HDAC3 (0.76) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5315936 0.84 KMT2A (0.58) KDM4EL3MBTL1HDAC3HDAC4HDAC1
SCHEMBL5316738 0.84 MEN1 (0.60) KDM4EL3MBTL1HDAC3HDAC4HDAC1
SCHEMBL1203341 0.79 PTK2 (0.54)
SCHEMBL5318662 0.79 HDAC3 (0.67) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6074331 0.77 HDAC3 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL19345939 0.75 ATIC (0.64) KDM4EL3MBTL1ATICALDH1A1AKT1
SCHEMBL773314 0.75 ALDH1A1 (0.68) L3MBTL1HDAC3HDAC4HDAC1HDAC7
SCHEMBL14579505 0.74 HDAC3 (0.64) KDM4EHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007067993-A1 INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2007-06-14 WO disclosed